↓ Skip to main content

American Association for Cancer Research

Article Metrics

Osimertinib, an Irreversible Next-Generation EGFR Tyrosine Kinase Inhibitor, Exerts Antitumor Activity in Various Preclinical NSCLC Models Harboring the Uncommon EGFR Mutations G719X or L861Q or S768I

Overview of attention for article published in Molecular Cancer Therapeutics, September 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
1 news outlet
twitter
4 tweeters
reddit
1 Redditor

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
9 Mendeley